BEHNAM JAFARPOUR: Open Payments
NPI 1033359336 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$13,958 in 205 payments from 32 companies in 2025. Trend: 2023 $2,949 · 2024 $23,310 · 2025 $13,958
Speaker / faculty: $10,500Food & beverage: $3,458
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 52 | $11,148 |
| Biogen, Inc. | 24 | $419 |
| Amneal Pharmaceuticals LLC | 14 | $328 |
| Abbott Laboratories | 13 | $306 |
| Lundbeck LLC | 11 | $250 |
| PFIZER INC. | 23 | $216 |
| Eisai Inc. | 9 | $140 |
| Celgene Corporation | 10 | $140 |
| Neurelis, Inc. | 7 | $122 |
| Novartis Pharmaceuticals Corporation | 4 | $88 |
Products named: QULIPTA, UBRELVY, CREXONT, PROCLAIM, LEQEMBI, NURTEC ODT, VYEPTI, TYSABRI.
Industry payments across MD — which companies pay providers there.
